Pacira BioSciences Inc (PCRX)
26.10
-0.67
(-2.50%)
USD |
NASDAQ |
Apr 18, 16:00
26.10
0.00 (0.00%)
After-Hours: 20:00
Pacira BioSciences Price: 26.10 for April 18, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 18, 2024 | 26.79 | 26.84 | 26.08 | 26.10 | 619110.0 |
Apr 17, 2024 | 27.02 | 27.14 | 26.36 | 26.77 | 415509.0 |
Apr 16, 2024 | 26.43 | 27.63 | 26.29 | 26.87 | 721374.0 |
Apr 15, 2024 | 26.89 | 27.04 | 25.76 | 26.53 | 604436.0 |
Apr 12, 2024 | 27.29 | 27.29 | 26.61 | 26.83 | 471623.0 |
Apr 11, 2024 | 28.09 | 28.09 | 27.22 | 27.36 | 323567.0 |
Apr 10, 2024 | 27.89 | 28.38 | 27.52 | 27.83 | 444858.0 |
Apr 09, 2024 | 28.60 | 28.84 | 27.98 | 28.52 | 363924.0 |
Apr 08, 2024 | 28.10 | 28.73 | 28.10 | 28.48 | 326414.0 |
Apr 05, 2024 | 28.37 | 28.45 | 27.94 | 28.16 | 415395.0 |
Apr 04, 2024 | 29.05 | 29.47 | 28.18 | 28.40 | 403193.0 |
Apr 03, 2024 | 28.33 | 29.12 | 28.26 | 29.01 | 307484.0 |
Apr 02, 2024 | 28.80 | 29.17 | 28.31 | 28.51 | 477032.0 |
Apr 01, 2024 | 29.44 | 29.44 | 28.42 | 29.15 | 335797.0 |
Mar 28, 2024 | 29.15 | 29.58 | 28.86 | 29.22 | 569631.0 |
Mar 27, 2024 | 28.73 | 29.30 | 28.36 | 29.04 | 556686.0 |
Mar 26, 2024 | 29.48 | 29.48 | 28.25 | 28.51 | 531750.0 |
Mar 25, 2024 | 28.87 | 29.40 | 28.60 | 29.23 | 383011.0 |
Mar 22, 2024 | 29.37 | 29.45 | 28.44 | 28.67 | 360010.0 |
Mar 21, 2024 | 30.16 | 30.39 | 29.22 | 29.29 | 535719.0 |
Mar 20, 2024 | 29.40 | 30.16 | 29.08 | 30.02 | 276565.0 |
Mar 19, 2024 | 29.23 | 29.72 | 28.86 | 29.47 | 287321.0 |
Mar 18, 2024 | 29.42 | 29.62 | 28.70 | 29.29 | 328012.0 |
Mar 15, 2024 | 29.02 | 29.68 | 28.82 | 29.41 | 1.256M |
Mar 14, 2024 | 30.27 | 30.27 | 29.11 | 29.26 | 445730.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
26.10
Minimum
Apr 18 2024
81.64
Maximum
Apr 08 2022
49.18
Average
47.24
Median
Price Benchmarks
Dynavax Technologies Corp | 11.35 |
Arbutus Biopharma Corp | 2.74 |
Chimerix Inc | 0.9205 |
Karyopharm Therapeutics Inc | 1.275 |
FibroGen Inc | 1.16 |
Price Related Metrics
PE Ratio | 31.45 |
PS Ratio | 2.117 |
PEG Ratio | 0.1875 |
Price to Book Value | 1.395 |
Price to Free Cash Flow | 10.24 |
Earnings Yield | 3.18% |
Market Cap | 1.214B |
PEGY Ratio | 0.1875 |
Operating PE Ratio | 16.36 |
Normalized PE Ratio | 23.08 |